Category: CBSA News

Join CBSA in asking Congress to support leading-edge health innovation by American life sciences companies. We are asking Congress to remove a “tax on innovation” by restoring the immediate expensing...

Partnership Led by Innosphere Ventures Lands Major Federal Grant  The U.S. Economic Development Administration validated Colorado’s collaborative approach to building a major national and interna...

CBSA and other members of the Council of State Bioscience Associations (CSBA) have submitted a letter to the Centers for Medicare & Medicaid Services (CMS) expressing our deep concern with a recen...

CBSA has serious concerns about the Colorado Prescription Drug Affordability Board’s inconsistent approach to the preliminary data review process for drugs under affordability review in the first coho...

In June 2022, World Trade Organization (WTO) member states agreed to waive certain WTO intellectual property protections for COVID-19 vaccines. The U.S. Trade Representative (USTR) has been considerin...

Weekly Policy Blog: CBSA Co-Hosts Facility Tours for State Legislators and Local Leaders  This month CBSA partnered with both Terumo Blood and Cell Technologies (Terumo BCT) and AGC Biologics to host...

For Immediate Release: October 13, 2023 Colorado BioScience Association to Honor Life Sciences Companies at 20th Annual Awards Celebration, Presented by AGC Biologics       En...

Earlier this month, CBSA participated in PASTEUR Advocacy Day, joining Biotechnology Innovation Organization (BIO) and other organizations, including Infectious Diseases Society of America, Cystic Fib...

Elyse Blazevich, President & CEO, Colorado BioScience Association Colorado’s life sciences community and our state leaders share an unwavering commitment to improving patient lives and making sure...

Fitzsimons Innovation Community presents a new white paper, entitled Choosing an Innovation Community, from a group of thought leaders in the Colorado bioscience and economic development communities....